Epidemiology of non fatal major adverse cardiovascular events in children with diabetes

被引：0
|
作者：
Ali, Ayad K. [1 ]
Lakshmanan, Mark C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
175
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [21] Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Nissen, SE
    Wolski, K
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20): : 2581 - 2586
  • [22] Achieving target SBP for lowering the risk of major adverse cardiovascular events in persons with diabetes mellitus
    Hartaigh, Brain O.
    Szymonifka, Jackie
    Okin, Peter M.
    JOURNAL OF HYPERTENSION, 2018, 36 (01) : 101 - 109
  • [23] Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without Diabetes
    Huang, Ruijue
    Li, Wenjia
    Xie, Zhen
    Zhuo, Kaimin
    Zhu, Jing
    ACADEMIC RADIOLOGY, 2024, 31 (09) : 3546 - 3556
  • [24] Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
    Fang-Ju Lin
    Wei-Kung Tseng
    Wei-Hsian Yin
    Hung-I Yeh
    Jaw-Wen Chen
    Chau-Chung Wu
    Scientific Reports, 7
  • [25] Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
    Lin, Fang-Ju
    Tseng, Wei-Kung
    Yin, Wei-Hsian
    Yeh, Hung-I
    Chen, Jaw-Wen
    Wu, Chau-Chung
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP
    Palm, Jonas
    Holdenrieder, Stefan
    Hoffmann, Georg
    Hoerer, Jurgen
    Shi, Ruibing
    Klawonn, Frank
    Ewert, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : 1890 - 1900
  • [27] Frailty is Associated With Perioperative Major Adverse Cardiovascular Events After Non-Cardiac Surgery
    Siddiqui, Emaad
    Banco, Darcy
    Berger, Jeffrey
    Smilowitz, Nathaniel
    CIRCULATION, 2021, 144
  • [28] Circulating Ceramides Predict Fatal and All Incident Major Adverse Cardiovascular Events: A Prospective Analysis of the FINRISK 2002 Cohort
    Havulinna, Aki S.
    Sysi-Aho, Marko
    Hurme, Reini
    Laaksonen, Reijo
    Salomaa, Veikko
    CIRCULATION, 2015, 132
  • [29] Dapagliflozin versus empagliflozin and major adverse cardiovascular events in type 2 diabetes: a nationwide cohort study
    Alhakak, A.
    Kober, L.
    Petrie, M. C.
    Jhund, P. S.
    Dridi, N. P.
    Karacan, M. N.
    Schou, M.
    Elmegaard, M.
    Rossing, P.
    Fosbol, E.
    Butt, J. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nation-wide cohort study
    Wesselhoeft, Rikke
    Hoejlund, Mikkel
    Wagner, Christina
    Andersen, Kjeld
    Fink-Jensen, Anders
    Hallas, Jesper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 66 - 66
12345